NAPLEX
Aug 25, 2025, 09:18
NAPLEX Study Guide – Warfarin Reversal Essentials
NAPLEX Study Guide shared an insightful post on X:
“NAPLEX MedFact
Reversing the effects of warfarin:
- Vitamin K (phytomenadione)
Promotes synthesis of clotting factors II, VII, IX, X.
Oral: slower onset, used for non-urgent reversal.
IV: faster onset, used for significant bleeding.
- Prothrombin Complex Concentrates (PCCs)
Contains concentrated clotting factors II, VII, IX, X.
Rapid reversal, especially in life-threatening bleeding.
Preferred over fresh frozen plasma for speed and lower volume.
- Fresh Frozen Plasma (FFP)
Provides clotting factors directly.
Slower and requires larger volume compared to PCC.
Used when PCC is unavailable or in certain clinical settings.
- Recombinant Activated Factor VII (rFVIIa)
Activates clotting cascade to bypass warfarin effect.
Used in critical cases; off-label.
Limited by high cost and thrombotic risk.”
Stay updated with Hemostasis Today.
-
Jul 30, 2026, 18:36Amina Ammar: Evaluating Rivaroxaban Dosing Alignment Across Cockcroft–Gault and eGFR Equations
-
Jul 30, 2026, 18:11Tobias Tritschler: Evaluating Timing, Translation and Preparedness in COVID-19 Anticoagulation Management
-
Jul 30, 2026, 16:05Peter Zdziarski: Today is Chronic Disease Awareness Day
-
Jul 30, 2026, 15:50Ahmad Gharehbaghian: New Blood Transfusion Centers Open in Iran
-
Jul 30, 2026, 15:32Can We Better Protect Hospitalized Patients With Obesity From Venous Thromboembolism? – RPTH Journal
-
Jul 30, 2026, 15:162025 Platelet Transfusion Thresholds: When to Transfuse and When Not to Transfuse – Chokri Ben Lamine
-
Jul 30, 2026, 14:34Flora Peyvandi: Genetics of Early-Onset Coronary Artery Disease in Iranians
-
Jul 30, 2026, 14:22Stéphanie Forté: New Evidence Strengthens the Case for Hydroxyurea in HbSC Disease
-
Jul 30, 2026, 14:09Hilal Ahmad: New Guidelines for Pediatric Ischemic Stroke Management